Pharma Focus Asia

News

Archives - 2007

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

Archives - 2008

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

August 2008

Enrollment in second phase 3 LymphoStat-B(R) trial complete

Wednesday 27 Aug, 2008

Phase III results of VELCADE(R) (Bortezomib) for injection

Wednesday 27 Aug, 2008

Astra Zeneca assigned RSV Licence

Tuesday 26 Aug, 2008

SF1126 found to block angiogenic signaling

Tuesday 26 Aug, 2008

Favorable results from Phase I/IIa Pandemic influenza vaccine program

Tuesday 26 Aug, 2008

Advancement in FRANCIS trial

Monday 25 Aug, 2008

FDA Approves ALOXI(R) (Palonosetron HCl) Capsules

Sunday 24 Aug, 2008

Enrollment complete in Phase III Trial of PRO 2000 for Indevus Pharmaceuticals

Friday 22 Aug, 2008

Phase I/II trial of Pomalidomide in relapsed and refractory multiple myeloma patients

Friday 22 Aug, 2008

OGX-011 granted Fast Track designation by FDA

Friday 22 Aug, 2008

Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer

Friday 22 Aug, 2008

Research collaboration announced by Cryo-Cell International and EndGenitor Technologies

Thursday 21 Aug, 2008

FDA expanded approval to VIDAZA(R), to include overall survival in higher-risk MDS

Thursday 21 Aug, 2008

Regulatory clearance to commence clinical study of Bio Vex’s vaccine candidate for Genital Herpes: ImmunoVEX HSV2.

Wednesday 20 Aug, 2008

Affitech and Omeros collaborate for antibody discovery and development

Tuesday 19 Aug, 2008

BMP Sunstone receives SFDA approval to manufacture multivitamin granules

Monday 18 Aug, 2008

AstraZeneca partners with Singapore institutions to develop anti-cancer compounds

Sunday 17 Aug, 2008

FDA approval for XENAZINE(R) (Tetrabenazine) for patients with Chorea associated with Huntington's disease

Sunday 17 Aug, 2008

Morphotek®, inc. signs license agreement with NCI for the development of a monoclonal antibody to treat prostate cancer

Wednesday 13 Aug, 2008

The Multiple Myeloma Research Consortium (MMRC) announces initiation of four-drug combination study to treat newly diagnosed multiple Myeloma patients

Wednesday 13 Aug, 2008

Oxygen Biotherapeutics develops gel version of Oxycyte®

Tuesday 12 Aug, 2008

FDA appoints orphan drug status to STX-100

Tuesday 12 Aug, 2008

Carna Biosciences enters agreement with Caliper Life Sciences

Friday 8 Aug, 2008

Cipher Pharmaceuticals enters into agreement with Ranbaxy for CIP-ISOTRETINOIN

Wednesday 6 Aug, 2008

Nutra Pharma collaborates with Centers for disease control and prevention

Wednesday 6 Aug, 2008

Capricorn Pharma and Teva Pharmaceuticals enter agreement for KORKOAT technology

Tuesday 5 Aug, 2008

UBC and CogState Ltd. enter partnership for cognitive assessment in clinical trials

Tuesday 5 Aug, 2008

HCT and Exforge approved by US FDA for treatment of high blood pressure

Monday 4 Aug, 2008

Kowa Company, Ltd. acquires ProEthic Pharmaceuticals, Inc.

Monday 4 Aug, 2008

ochremedia © 2008 Ochre Media. All rights reserved.